The Claim

2-Chlorohexadecanal (2-ClHDyA) reduces mitochondrial pyruvate respiration in human small airway epithelial cells, specifically decreasing ATP-linked oxygen consumption and indicating impaired energy production.

Source: Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
3score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

A chemical called 2-ClHDyA makes it harder for human lung cells to produce energy by reducing how much oxygen they use when burning fuel, which means the cells can't work as well.

See the scientific wording

2-Chlorohexadecanal (2-ClHDyA) reduces mitochondrial pyruvate respiration in human small airway epithelial cells, specifically decreasing ATP-linked oxygen consumption, indicating impaired energy production.

What the research says

1 study

  1. Study: Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes

    The study shows that the chemical 2-chlorohexadecanal makes cells use less energy by reducing how well their mitochondria work, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.